GSBD vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GSBD presents as a classic value trap, characterized by a stable Piotroski F-Score of 4/9 but severely compromised by deteriorating fundamentals. While the Graham Number of $17.12 suggests defensive undervaluation and the stock trades at a discount to book (0.76x), these are offset by a catastrophic dividend payout ratio of 135.92% and double-digit declines in both revenue (-17.10%) and earnings (-34.70%). The disconnect between the high dividend yield and the actual earnings capacity indicates a high probability of a dividend cut. Technical trends are completely bearish (0/100), confirming a lack of market confidence despite the low P/E ratio.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
GSBD vs JPM: Head-to-Head Comparison
This page compares Goldman Sachs BDC, Inc. (GSBD) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.